Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Exelixis, Inc. (EXEL) Profit Margins

Over the twelve months to 2026-07-03, Exelixis, Inc. (EXEL) had operating margin 39.9%, net margin 35.3%, free cash flow margin 48.1%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

EXELExelixis, Inc.Follow EXEL — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
16.0B
P/E TTM
20.3
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days
LineFY2011
Dec 11
FY2012
Dec 12
FY2013
Dec 13
FY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Jan 20
FY2020
Jan 21
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Jan 25
FY2025
Jan 26
TTM
Jul 26
Trend
Gross margin——96.4%91.9%89.5%96.6%96.7%96.9%96.6%96.3%96.3%96.4%96.0%96.5%96.4%—
Operating margin30.9%-258.0%-640.5%-893.9%-326.6%-14.7%36.7%51.4%38.2%11.1%20.0%12.5%9.3%27.9%37.6%39.9%
Net margin26.1%-306.3%-760.1%-1040.6%-435.1%-36.7%34.1%80.8%33.2%11.3%16.1%11.3%11.4%24.0%33.7%35.3%
FCF margin-55.3%-265.3%-641.2%-939.3%-382.1%106.9%31.9%44.8%53.1%18.1%24.2%20.8%16.0%31.0%37.7%48.1%

USD billions · SEC XBRL

Exelixis, Inc. — questions

What is Exelixis, Inc.'s operating margin?
39.9% over the twelve months to 2026-07-03.
What is Exelixis, Inc.'s net profit margin?
35.3% over the twelve months to 2026-07-03.

Every figure on this page comes from Exelixis, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.